Ondas focais para Impotência sexual

Opção inovadora para o tratamento da disfunção erétil SÃO PAULO, 25 de maio de 2023 /PRNewswire/ — O tratamento inovador de ondas focais de baixa intensidade tem sido utilizado como uma opção não invasiva para o tratamento da disfunção erétil. Essa terapia é considerada uma inovação na medicina pois é a única que estimula a … Read more

Wave Petunias Highlights 4 Science-Backed Ways Flowers can Improve Overall Wellness

WEST CHICAGO, Ill., May 25, 2023 /PRNewswire/ — Most people smile when they see a colorful, sweet-smelling garden of flowers, but the health and happiness benefits last long after that! From improved mood to lowered anxiety, psychologists studying well-being believe in the power of flowers. This article covers four science-backed benefits that prove flowers could be a … Read more

EuroPCR 2023 | Résultats à 6 mois de l’étude SMART : contrôle satisfaisant de la pression artérielle obtenu avec une charge médicamenteuse réduite

PARIS, 20 mai 2023 /PRNewswire/ — Le 17 mai 2023, les résultats à six mois de l’étude SMART (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial ; NCT02761811) ont été publiés lors de la conférence Late Breaking Clinical Trial, faisant état de découvertes révolutionnaires dans le domaine de l’hypertension. Avec le professeur Huo Yong comme … Read more

Two Chairs Recognized as a 2023 Bay Area Best Places to Work

With 50% of U.S. behavioral care providers reporting burnout, Two Chairs emerges as a workplace of choice for therapists interested in practicing at the top of their license Two Chairs therapists practice evidence, measurement, and outcomes-based care, supported by advanced clinical technology SAN FRANCISCO, May 19, 2023 /PRNewswire/ — Two Chairs, a modern behavioral healthcare … Read more

Two-Year Study Proves Coordinated Community-Based Care Improves Postpartum Health Outcomes for Expecting Mothers

Unite Us and First 1,000 Days Suncoast in Partnership with Sarasota Memorial Hospital reveals trailblazing results, healthcare savings and improved postpartum health outcomes from health and social service coordination, study shows. NEW YORK, May 19, 2023 /PRNewswire/ — Unite Us, the nation’s leading software company enabling cross-sector collaboration to improve people’s health and well-being, and … Read more

Euro PCR 2023 | Resultado a los 6 meses del estudio SMART

– Euro PCR 2023 | Resultado a los 6 meses del estudio SMART: control satisfactorio de la PA logrado con una carga de medicación reducida PARÍS, 19 de mayo, 2023 /PRNewswire/ — El 17 de mayo de 2023, se publicó el resultado de seis meses del estudio SMART (Sympathetic Mapping/Ablation Renal Nervers for Treatment of Hypertension … Read more

EuroPCR 2023 | 6-Monats-Ergebnisse der SMART-Studie: zufriedenstellende Blutdruckkontrolle bei reduzierter Medikamentenbelastung erreicht

PARIS, 19. Mai 2023 /PRNewswire/ — Am 17. Mai 2023 wurde das Sechsmonatsergebnis der SMART-Studie (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial; NCT02761811) auf der Late Breaking Clinical Trial-Konferenz veröffentlicht, die bahnbrechende Ergebnisse auf dem Gebiet des Bluthochdrucks liefert. Unter der Leitung von Professor Huo Yong und mit SyMap Medical (Suzhou) Ltd. als Sponsor … Read more

EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control achieved with reduced medication burden

PARIS, May 19, 2023 /PRNewswire/ — On May 17th 2023, the six-month result of the SMART Study (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial; NCT02761811) was released on the Late Breaking Clinical Trial conference, reporting ground-breaking findings in the field of hypertension. With Professor Huo Yong as the leading investigator and SyMap Medical (Suzhou) … Read more

HuidaGene Therapeutics Announces Publication of the World’s First Guanine Base-Editor

SHANGHAI and CLINTON, N.J., May 18, 2023 /PRNewswire/ — HuidaGene Therapeutics (辉大基因; HuidaGene), a clinical-stage genome-editing company, today announced the online National Science Review published the comprehensive data from a study of the world’s first DNA base editor converting G-to-Y, glycosylase-based guanine base editor (gGBE). Company has filed an international patent application for this base … Read more

New Poll Shows Americans See Benefit of Medtech in Diabetes Management, Support Government Investment in Research and Cures

WASHINGTON, May 18, 2023 /PRNewswire/ — A new national poll conducted by Morning Consult on behalf of AdvaMed, the medtech association, found that an overwhelming number of Americans believe medical technology plays a significant role in treating and improving the health and wellbeing of those living with diabetes, but those diagnosed with the disease struggle to … Read more